This inventor holds 2 USPTO granted patents and 1 published patent application and 2 EPO patents. Top assignee: Daewoo Pharmaceutical Ind. Co., Ltd.. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015
Title: Innovations of Kyung-Ran Kang in Anti-Inflammatory and Anti-Angiogenic Research
Introduction
Kyung-Ran Kang is a notable inventor based in Busan, South Korea. He has made significant contributions to the field of pharmaceutical compositions, particularly focusing on anti-inflammatory and anti-angiogenic agents. With a total of 2 patents, his work has the potential to impact various medical applications.
Latest Patents
Kyung-Ran Kang's latest patents include an anti-inflammatory composition containing macrolactin A and its derivatives. This invention highlights the anti-inflammatory properties of macrolactin compounds, which are derived from a novel strain of KJS-2 (KCCM10769P). The compounds have been shown to effectively suppress the expression of inducible nitric oxide synthetase (iNOS) and cyclooxygenase-2 (COX-2), which are crucial in the inflammatory response. Additionally, these compounds inhibit the formation of nitric oxide (NO) and prostaglandin E2 (PGE2), thereby providing excellent anti-inflammatory agents.
Another significant patent by Kang is an anti-angiogenic composition that also utilizes macrolactin A and its derivatives. This composition has demonstrated strong suppression of angiogenesis in in vivo experiments, indicating its potential as a pharmaceutical composition for preventing or treating diseases associated with angiogenesis.
Career Highlights
Kyung-Ran Kang is currently associated with Daewoo Pharmaceutical Ind. Co., Ltd., where he continues to innovate in the field of pharmaceuticals. His research focuses on developing effective treatments that leverage the unique properties of macrolactin compounds.
Collaborations
Kang has collaborated with notable colleagues, including Young-Hoon Ji and Dong-Hee Kim, who contribute to the research and development of his innovative projects.
Conclusion
Kyung-Ran Kang's work in developing anti-inflammatory and anti-angiogenic compositions showcases his commitment to advancing medical science. His patents reflect a promising future for treatments that can significantly improve patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile